Evaluation of Right Ventricular Systolic Function by TAPSE Parameter From Subcostal View

Echocardiographic Evaluation of Right Ventricular Systolic Function by TAPSE Parameter Measured From Subcostal View Using Anatomical M-mode - Validation Clinical Study

The purpose of this study is to validate a new echocardiographic parameter evaluating right ventricular function.

Study Overview

Detailed Description

The key conventional echocardiographic parameter evaluating right ventricular systolic function is the tricuspid annular plane systolic excursion (TAPSE). It is measured in apical four chamber view by conventional M-mode imaging. Other echocardiographic parameters of right ventricular systolic function (Fractional Area Change; Tricuspid Lateral Annular Systolic Velocity; Right Ventricular Index of Myocardial Performance) are evaluated in apical four chamber view as well. However, this view might not be clearly visible in the clinical setting of critical illness and subcostal view is often preferred for its higher quality. Unfortunately, conventional M-mode can not be used for measurement in this view but anatomical M-mode imaging can. Therefore, the investigators decided to evaluate whether TAPSE measured in subcostal view by anatomical M-mode (sTAPSE) correlates with conventional TAPSE and whether reliably reflects systolic right ventricular function.

Study Type

Observational

Enrollment (Anticipated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Roman Skulec, MD, PhD
  • Phone Number: 00420777577497
  • Email: skulec@email.cz

Study Contact Backup

Study Locations

      • Usti nad Labem, Czechia, 40113
        • Recruiting
        • Masaryk Hospital Usti nad Labem
        • Contact:
          • Roman Skulec, MD, PhD
          • Phone Number: 00420777577497
          • Email: skulec@email.cz

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Adult intensive care unit patients.

Description

Inclusion Criteria:

  • Inpatients
  • All patients hospitalised in intensive care unit indicated for transthoracic echocardiography examination

Exclusion Criteria:

  • Age <18 years
  • Insufficient imaging quality of transthoracic echocardiography
  • Refusal of echocardiographic examination by patient

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Critically ill patients
Critically ill patients hospitalised at the intensive care unit indicated to echocardiographic examination.
Conventional transthoracic echocardiographic examination at the intensive care unit.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Validity of sTAPSE in prediction of right ventricular systolic dysfunction
Time Frame: During the intervention
sTAPSE is a new potential echocardiographic parameter of right ventricular systolic function measurable from subcostal view.
During the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation of sTAPSE with conventional TAPSE
Time Frame: During the intervention
sTAPSE is a new potential echocardiographic parameter of right ventricular systolic function measurable from subcostal view.
During the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Roman Skulec, MD, PhD, Masaryk Hospital Usti nad Labem

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 27, 2020

Primary Completion (Anticipated)

September 30, 2020

Study Completion (Anticipated)

October 31, 2020

Study Registration Dates

First Submitted

July 19, 2020

First Submitted That Met QC Criteria

July 26, 2020

First Posted (Actual)

July 29, 2020

Study Record Updates

Last Update Posted (Actual)

August 19, 2020

Last Update Submitted That Met QC Criteria

August 18, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 284/34

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Transthoracic Echocardiography

Clinical Trials on Transthoracic echocardiography

3
Subscribe